TrueBlue, Inc. (TBI)
NYSEIndustrialsStaffing & Employment ServicesSnapshot 2026-09-04
$9.85-0.71%
Close 2026-09-04 · 1-day change
NYSEIndustrialsStaffing & Employment ServicesSnapshot 2026-09-04
Intact: The reason to own it still holds.
TrueBlue is growing through mergers and acquisitions. It beat earnings in 2026-Q1. Management is working to fix losses. The stock gained nearly 99% in 63 days.
TrueBlue lost $19.8 million in 2026-Q1. Earnings are expected negative for full 2026. The company is still unprofitable and risky.
The market expects a small profit in 2026-Q3 but a loss for full 2026. Our view sees risk in earnings recovery.
Breaks if: EPS remains negative or below $0.17 in 2026-Q3 and 2027
Breaks if: No material M&A deals completed or announced in 2026
Net income remains negative through 2027
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story with a focus on strategic acquisitions and operational discipline. The current thesis state indicates a cautious optimism, as recent financial performance has been weak but shows some signs of improvement.
The market appears to price TBI as a cheap option compared to its peers, with a notable expectations gap suggesting that investors are not fully confident in its recovery. The current valuation reflects a justified stance, but with low model confidence.
Management is on track with priorities such as M&A activity and cost discipline, which could help improve profitability over time. However, the company remains loss-making, and recent financial performance has been weak, indicating potential challenges ahead.
The long-term thesis hinges on management's ability to execute on growth initiatives and maintain operational discipline. Additionally, the performance of sector bellwethers could significantly impact TBI's momentum, either supporting or hindering its recovery.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports financial performance and earnings results. Better Q2 guidance reinforces this positive outlook. There are no new threats impacting the thesis.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
In summary, TBI's outlook is mixed, with potential for improvement if management executes well and sector conditions remain favorable. Not investment advice.